Genomic Health's CEO Discusses Q4 2012 Results – Earnings Call Transcript

Genomic Health's CEO Discusses Q4 2012 Results – Earnings Call Transcript

Filed under: drug treatment programs in san francisco

Specifically, this year we plan to initiate additional large DCIS clinical study to confirm and extend the findings of the landmark ECOG E-5194 study, to conduct a colon oxaliplatin treatment validation study for prediction in stage 3 disease, a large …
Read more on Seeking Alpha

 

Bladder cancer gets little attention, research funding

Filed under: drug treatment programs in san francisco

SAN FRANCISCO, Ca. – For at least six months, Michael Bailey's doctors assumed that the blood in his urine came from a kidney stone or a urinary tract infection. After the bleeding persisted, his doctor persuaded him to have a cystoscopy, a procedure …
Read more on KERO-TV 23

 

Path Names Dr. Hing Sham to Lead Drug Research and Preclinical Development

Filed under: drug treatment programs in san francisco

In his new role with PATH's drug development team, based in South San Francisco, Dr. Sham will be involved with discovery and preclinical research for PATH's drug development portfolio. He will drive the development of the existing product pipeline and …
Read more on AllAfrica.com

 

Leave a Reply

Your email address will not be published. Required fields are marked *